Holdings of Franklin Biotechnology Discovery Fund
Franklin Strategic Series · Original filing · Compare with another fund · Report an error
- Net assets
- 1.2B $ including 1.1B $ in equities, 94.6 %
- Positions
- 98 in 11 countries
- Top ten
- 35.6 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | JAZZ PHARMACEUTICALS PLC | 258,371 | 65.3M $ | 5.66 % |
| 2 | Amgen Inc | 131,554 | 50.7M $ | 4.39 % |
| 3 | Gilead Sciences Inc | 341,817 | 44.5M $ | 3.86 % |
| 4 | Regeneron Pharmaceuticals Inc | 57,013 | 43.5M $ | 3.77 % |
| 5 | Argenx SE | 48,962 | 41.8M $ | 3.62 % |
| 6 | Vertex Pharmaceuticals Inc | 85,620 | 40.8M $ | 3.54 % |
| 7 | REVOLUTION MEDICINES INC | 185,428 | 34.8M $ | 3.01 % |
| 8 | GUARDANT HEALTH INC | 196,520 | 31.8M $ | 2.76 % |
| 9 | Ascendis Pharma A/S | 121,287 | 29.6M $ | 2.56 % |
| 10 | ORUKA THERAPEUTICS INC | 296,262 | 28.6M $ | 2.48 % |
| 11 | Dianthus Therapeutics Inc | 250,308 | 26.8M $ | 2.32 % |
| 12 | Spyre Therapeutics Inc | 245,009 | 24.1M $ | 2.09 % |
| 13 | Insmed Inc | 233,052 | 23M $ | 1.99 % |
| 14 | MIRUM PHARMACEUTICALS INC | 215,190 | 22.8M $ | 1.98 % |
| 15 | Praxis Precision Medicines Inc | 71,799 | 22.1M $ | 1.91 % |
| 16 | Neurocrine Biosciences Inc | 125,643 | 21M $ | 1.82 % |
| 17 | Bridgebio Pharma Inc | 241,119 | 19.3M $ | 1.67 % |
| 18 | PTC Therapeutics Inc | 279,737 | 19M $ | 1.65 % |
| 19 | AstraZeneca PLC | 102,531 | 17.4M $ | 1.51 % |
| 20 | AMYLYX PHARMACEUTICALS INC | 752,824 | 15.3M $ | 1.32 % |
| 21 | Eli Lilly & Co | 13,131 | 15.1M $ | 1.31 % |
| 22 | CYTOKINETICS INC | 186,018 | 14.3M $ | 1.24 % |
| 23 | Tango Therapeutics Inc | 521,761 | 14.2M $ | 1.23 % |
| 24 | EyePoint Inc | 1,123,495 | 13.8M $ | 1.19 % |
| 25 | ABIVAX SA | 109,022 | 13.6M $ | 1.18 % |
| 26 | Mineralys Therapeutics Inc | 533,511 | 13.6M $ | 1.18 % |
| 27 | Arcutis Biotherapeutics Inc | 505,651 | 13.6M $ | 1.18 % |
| 28 | Indivior Pharmaceuticals Inc | 332,496 | 13.3M $ | 1.15 % |
| 29 | Thermo Fisher Scientific Inc | 22,999 | 13.2M $ | 1.14 % |
| 30 | DYNE THERAPEUTICS INC | 519,232 | 13.1M $ | 1.13 % |
| 31 | Bicara Therapeutics Inc | 474,899 | 12.9M $ | 1.12 % |
| 32 | CG ONCOLOGY INC | 174,532 | 12.4M $ | 1.08 % |
| 33 | Benitec Biopharma Inc | 995,152 | 11.7M $ | 1.01 % |
| 34 | Alkermes PLC | 232,937 | 11.4M $ | 0.99 % |
| 35 | Solid Biosciences Inc | 1,409,093 | 11.4M $ | 0.98 % |
| 36 | Syndax Pharmaceuticals Inc | 582,815 | 11.1M $ | 0.96 % |
| 37 | IONIS PHARMACEUTICALS INC | 209,423 | 10.8M $ | 0.94 % |
| 38 | BEONE MEDICINES LTD | 33,421 | 10.6M $ | 0.92 % |
| 39 | ALNYLAM PHARMACEUTICALS INC | 51,286 | 10.5M $ | 0.91 % |
| 40 | Contineum Therapeutics Inc | 625,148 | 9.7M $ | 0.84 % |
| 41 | JADE BIOSCIENCES INC | 479,949 | 9.5M $ | 0.82 % |
| 42 | Alto Neuroscience Inc | 347,904 | 9.4M $ | 0.82 % |
| 43 | VAXCYTE INC | 145,674 | 7.9M $ | 0.68 % |
| 44 | Xenon Pharmaceuticals Inc | 123,767 | 7.8M $ | 0.67 % |
| 45 | Relay Therapeutics Inc | 404,940 | 7.6M $ | 0.66 % |
| 46 | ORIC Pharmaceuticals Inc | 659,005 | 7.3M $ | 0.63 % |
| 47 | Neurogene Inc | 218,783 | 7.2M $ | 0.62 % |
| 48 | ACHIEVE LIFE SCIENCES INC | 1,095,791 | 7M $ | 0.61 % |
| 49 | BioNTech SE | 73,400 | 6.6M $ | 0.58 % |
| 50 | STRUCTURE THERAPEUTICS INC | 136,424 | 6.6M $ | 0.57 % |
| 51 | Olema Pharmaceuticals Inc | 568,915 | 6.5M $ | 0.56 % |
| 52 | MBX BIOSCIENCES INC | 85,528 | 5.6M $ | 0.49 % |
| 53 | Artiva Biotherapeutics Inc | 542,371 | 5.5M $ | 0.47 % |
| 54 | Aura Biosciences Inc | 765,617 | 5.4M $ | 0.47 % |
| 55 | NEWAMSTERDAM PHARMA COMPANY NV | 187,726 | 5.2M $ | 0.45 % |
| 56 | Sionna Therapeutics Inc | 107,956 | 5.1M $ | 0.44 % |
| 57 | Krystal Biotech Inc | 14,607 | 5M $ | 0.43 % |
| 58 | SENSEI BIOTHERAPEUTICS INC | 180,711 | 4.9M $ | 0.43 % |
| 59 | INVENTIVA SA | 1,014,919 | 4.5M $ | 0.39 % |
| 60 | Phathom Pharmaceuticals Inc | 507,425 | 4.4M $ | 0.38 % |
| 61 | Relmada Therapeutics Inc | 788,718 | 4.2M $ | 0.36 % |
| 62 | Palisade Bio Inc | 2,119,910 | 4M $ | 0.35 % |
| 63 | Celcuity Inc | 46,107 | 4M $ | 0.35 % |
| 64 | uniQure NV | 88,716 | 3.9M $ | 0.34 % |
| 65 | Definium Therapeutics Inc | 86,980 | 3.8M $ | 0.33 % |
| 66 | Oculis Holding AG | 314,736 | 3.6M $ | 0.31 % |
| 67 | AVALYN PHARMA INC | 120,364 | 3.5M $ | 0.30 % |
| 68 | Satellos Bioscience, Inc. | 343,237 | 3.4M $ | 0.30 % |
| 69 | VERADERMICS INC | 31,081 | 3.3M $ | 0.28 % |
| 70 | GRAIL Inc | 46,433 | 3.2M $ | 0.28 % |
| 71 | Parabilis Medicines Inc | 93,010 | 3.2M $ | 0.27 % |
| 72 | VOR BIOPHARMA INC | 148,745 | 3.1M $ | 0.27 % |
| 73 | KARDIGAN INC | 144,820 | 3M $ | 0.26 % |
| 74 | Immix Biopharma Inc | 357,034 | 3M $ | 0.26 % |
| 75 | COGENT BIOSCIENCES INC | 75,829 | 3M $ | 0.26 % |
| 76 | Ideaya Biosciences Inc | 81,852 | 2.9M $ | 0.25 % |
| 77 | AVALO THERAPEUTICS INC | 147,877 | 2.7M $ | 0.23 % |
| 78 | Ultragenyx Pharmaceutical Inc | 108,067 | 2.7M $ | 0.23 % |
| 79 | SCRIBE THERAPEUTICS INC | 135,567 | 2.6M $ | 0.23 % |
| 80 | Kailera Therapeutics Inc | 146,385 | 2.5M $ | 0.21 % |
| 81 | CABALETTA BIO INC | 876,846 | 2.3M $ | 0.20 % |
| 82 | VERASTEM INC | 401,744 | 2.3M $ | 0.20 % |
| 83 | Adicet Bio Inc | 225,186 | 2.1M $ | 0.18 % |
| 84 | TYRA BIOSCIENCES INC | 62,752 | 2M $ | 0.17 % |
| 85 | Sartorius Stedim Biotech | 10,100 | 2M $ | 0.17 % |
| 86 | SpyGlass Pharma Inc | 84,708 | 1.9M $ | 0.17 % |
| 87 | Odyssey Therapeutics Inc | 99,826 | 1.9M $ | 0.16 % |
| 88 | Acumen Pharmaceuticals Inc | 826,400 | 1.8M $ | 0.15 % |
| 89 | JATT II Acquisition Corp. | 146,753 | 1.8M $ | 0.15 % |
| 90 | Vicore Pharma Holding AB | 130,759 | 1.4M $ | 0.12 % |
| 91 | BioAge Labs Inc | 135,049 | 1.2M $ | 0.11 % |
| 92 | Eikon Therapeutics Inc | 127,376 | 1.2M $ | 0.10 % |
| 93 | ASSEMBLY BIOSCIENCES INC | 40,982 | 1M $ | 0.09 % |
| 94 | Context Therapeutics Inc | 1,398,833 | 838.5K $ | 0.07 % |
| 95 | INFLARX NV | 376,105 | 639.4K $ | 0.06 % |
| 96 | Cardiff Oncology Inc | 438,961 | 375.5K $ | 0.03 % |
| 97 | IN8BIO INC | 332,083 | 345.4K $ | 0.03 % |
| 98 | Vicore Pharma Holding AB | 8 | 9.3 $ |
Sector breakdown
- Health care 28.5 %
- Unattributed 71.5 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 99.8 %
- EUR 0.2 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 79.9 %
- Ireland 7.0 %
- Netherlands 4.7 %
- Denmark 2.7 %
- France 1.8 %
- United Kingdom 1.6 %
- Canada 1.0 %
- Germany 0.6 %
- Switzerland 0.3 %
- Cayman Islands 0.2 %
- Sweden 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 80 | 872M $ | 79.86 % |
| 2 | Ireland | 2 | 76.7M $ | 7.03 % |
| 3 | Netherlands | 4 | 51.5M $ | 4.72 % |
| 4 | Denmark | 1 | 29.6M $ | 2.71 % |
| 5 | France | 3 | 20.1M $ | 1.84 % |
| 6 | United Kingdom | 1 | 17.4M $ | 1.59 % |
| 7 | Canada | 2 | 11.2M $ | 1.02 % |
| 8 | Germany | 1 | 6.6M $ | 0.61 % |
| 9 | Switzerland | 1 | 3.6M $ | 0.33 % |
| 10 | Cayman Islands | 1 | 1.8M $ | 0.16 % |
| 11 | Sweden | 2 | 1.4M $ | 0.13 % |
Cite this page
Titelia. "Holdings of Franklin Biotechnology Discovery Fund". https://titelia.com/en/funds/S000006882